Beacon Tip Sizing Catheter and Slip-Cath Beacon Tip Catheter Study

Last updated: July 15, 2025
Sponsor: Cook Research Incorporated
Overall Status: Active - Recruiting

Phase

N/A

Condition

Occlusions

Stroke

Abnormal Blood Vessels (Arteriovenous Malformations)

Treatment

Beacon Tip Catheters

Clinical Study ID

NCT06986954
24-01
  • All Genders

Study Summary

This prospective observational post-market clinical study will collect data in the United States to primarily support the re-launch of the re-designed Beacon Tip Sizing Catheter and Slip-Catheter Beacon Tip Catheter & Shuttle Select Slip-Catheter (Visceral and Cerbral) for a Conformité Européenne (CE) Mark application in the European Union (EU). Additionally, the data from this study may be used to support regulatory approval in other countries/regions.

The purpose of this clinical study is to evaluate the safety and performance of these catheters in accordance with the Intended Use through the end of index procedure, and through 30 days post procedure, (as applicable as data is available) to ensure an acceptable benefit:risk ratio.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • A patient is deemed suitable for inclusion in this study if the patient undergoes aprocedure using an applicable Beacon Tip Catheter.

Exclusion

Exclusion Criteria:

  • Patient or his/her legally authorized representative objects to collection andprocessing of his/her data, or not willing to accept the use of an Informed Consentwaiver or the data protection notice (if utilized).

Study Design

Total Participants: 588
Treatment Group(s): 1
Primary Treatment: Beacon Tip Catheters
Phase:
Study Start date:
April 20, 2025
Estimated Completion Date:
July 31, 2026

Connect with a study center

  • Vascular Breakthroughs

    Darien, Connecticut 06820
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.